Skip to content
← Survival collections

CANCER EVIDENCE

Long-Term Trends

33 published cancer groups · 1,032 source series. Choose a group to explore its populations.

Acute Lymphocytic Leukemia (ALL)

36 source series

→

Acute Myeloid Leukemia (AML)

36 source series

→

All Cancer Sites Combined

36 source series

→

Anus, Anal Canal & Anorectum

36 source series

→

Bones and Joints

36 source series

→

Brain and Other Nervous System

36 source series

→

Breast

24 source series

→

Cervix Uteri

12 source series

→

Chronic Lymphocytic Leukemia (CLL)

36 source series

→

Chronic Myeloid Leukemia (CML)

36 source series

→

Colon and Rectum (including Appendix)

36 source series

→

Corpus and Uterus, NOS

12 source series

→

Esophagus

36 source series

→

Hodgkin Lymphoma

36 source series

→

Kidney and Renal Pelvis

36 source series

→

Larynx

36 source series

→

Leukemia

36 source series

→

Liver and Intrahepatic Bile Duct

36 source series

→

Lung and Bronchus

36 source series

→

Melanoma of the Skin

36 source series

→

Myeloma

36 source series

→

Non-Hodgkin Lymphoma

36 source series

→

Oral Cavity and Pharynx

36 source series

→

Ovary

12 source series

→

Pancreas

36 source series

→

Prostate

12 source series

→

Small Intestine

36 source series

→

Soft Tissue including Heart

36 source series

→

Stomach

36 source series

→

Testis

12 source series

→

Thyroid

36 source series

→

Urinary Bladder (Invasive & In Situ)

36 source series

→

Vulva

12 source series

→

Preserved source evidence · Independent clinical review pending · Not medical advice

SEER survival populations | Triangle